Sign in
4

Changes in Ownership

Immunovant, Inc. Filed Acc 0001764013-25-000053

Chief Medical Officer acquired 101,574 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Geffner Michael Chief Medical Officer 2025-04-01 Grant or award +101,574 233,888 D
Derivatives
Geffner Michael Chief Medical Officer 2025-04-01 Grant or award · Stock Option (right to buy) +143,063 143,063 D
Loading xslF345X05/wk-form4_1743713398.xml…